Precision oncology and patient stratification
3 European H2020 organizations list this as part of their work — 3 as their primary capability.
Most active in this area
- FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
Barcelona cancer research institute specializing in precision oncology, liquid biopsies, patient stratification, and translational clinical trials across multiple tumor types.
“Central theme across COLOSSUS (colorectal), MESI-STRAT (breast), LEGACy (gastric), CCE_DART (biomarker-driven trials), HARMONY (hematological), and MoTriColor (molecularly guided trials).”
PrimaryES23 projects - INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
London-based cancer research institute specialising in tumour evolution, precision oncology, structural biology, and therapeutic ultrasound across 16 H2020 projects.
“B-CAST (breast cancer molecular subtypes), COLOSSUS (colorectal cancer multi-omics stratification), VAGABOND and ITCC-P4 (paediatric cancer actionable genomics and preclinical platforms).”
PrimaryUK16 projects - GENEXPLAIN GMBH
German bioinformatics SME specializing in computational disease modeling, multi-omics analysis, and precision medicine for cancer and neurodegeneration.
“COLOSSUS focuses on multi-omics-based patient stratification in metastatic colorectal cancer; GLIOTRAIN addresses glioblastoma research.”
PrimarySMEDE5 projects